Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
August 19, 2024Ophthalmic ResearchOpen Access

Real-life results after the administration of a single 0.19 mg fluocinolone acetonide (ILUVIEN®) implant in patients with refractory diabetic macular edema

View Full Paper
Ask AI
Bookmark
Share

Authors

WDWarda DarwischMWMaria della Volpe WaizelPRPhilipp Roberts

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Darwisch et al. (2024) studied this question.

synapsesocial.com/papers/68e5bc37b6db6435875543cfhttps://doi.org/10.1159/000540459
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Efficacy and Safety Outcomes of Fluocinolone Acetonide Intravitreal Implant in Refractory Diabetic Macular Edema: A Real-World Study2026
  2. 2Fluocinolone acetonide implant in diabetic macular edema: sustained benefits and effects of following prior therapy2026
  3. 3Intravitreal fluocinolone acetonide implant for diabetic macular edema – 2-year results from IDEAL, a prospective German observational study2026
  4. 4Use of intravitreal fluocinolone acetonide implant in inflammatory macular oedema2026 · 1 citations
  5. 5Fluocinolone Acetonide Implant for Uveitis: Dissecting Responder and Non-Responder Outcomes at a Tertiary Center2024 · 9 citations